Literature DB >> 1695717

A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.

G R Cutting1, L M Kasch, B J Rosenstein, J Zielenski, L C Tsui, S E Antonarakis, H H Kazazian.   

Abstract

The gene responsible for cystic fibrosis (CF) has recently been identified and is predicted to encode a protein of 1,480 amino acids called the CF transmembrane conductance regulator (CFTR). Several functional regions are thought to exist in the CFTR protein, including two areas for ATP-binding, termed nucleotide-binding folds (NBFs), a regulatory (R) region that has many possible sites for phosphorylation by protein kinases A and C, and two hydrophobic regions that probably interact with cell membranes. The most common CF gene mutation leads to omission of phenylalanine residue 508 in the putative first NBF, indicating that this region is functionally important. To determine whether other mutations occur in the NBFs of CFTR, we determined the nucleotide sequences of exons 9, 10, 11 and 12 (encoding the first NBF) and exons 20, 21 and 22 (encoding most of the second NBF) from 20 Caucasian and 18 American-black CF patients. One cluster of four mutations was discovered in a 30-base-pair region of exon 11. Three of these mutations cause amino-acid substitutions at residues that are highly conserved among the CFTR protein, the multiple-drug-resistance proteins and ATP-binding membrane-associated transport proteins. The fourth mutation creates a premature termination signal. These mutations reveal a functionally important region in the CFTR protein and provide further evidence that CFTR is a member of the family of ATP-dependent transport proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695717     DOI: 10.1038/346366a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  129 in total

1.  Genome analysis: Assigning protein coding regions to three-dimensional structures.

Authors:  A A Salamov; M Suwa; C A Orengo; M B Swindells
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Mode of action and application of Scorpion primers to mutation detection.

Authors:  N Thelwell; S Millington; A Solinas; J Booth; T Brown
Journal:  Nucleic Acids Res       Date:  2000-10-01       Impact factor: 16.971

3.  Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis.

Authors:  DeeDee Lafayette; Dianne Abuelo; Mary Ann Passero; Umadevi Tantravahi
Journal:  J Genet Couns       Date:  1999-02       Impact factor: 2.537

4.  Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting.

Authors:  R Ratcliff; M J Evans; J Doran; B J Wainwright; R Williamson; W H Colledge
Journal:  Transgenic Res       Date:  1992-07       Impact factor: 2.788

5.  Mutations in the linker domain of NBD2 of SUR inhibit transduction but not nucleotide binding.

Authors:  Michinori Matsuo; Michael Dabrowski; Kazumitsu Ueda; Frances M Ashcroft
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family.

Authors:  A Curtis; R J Richardson; J Boohene; A Jackson; R Nelson; S S Bhattacharya
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

7.  A novel mutation in exon 3 of the CFTR gene.

Authors:  H Guillermit; M Jéhanne; I Quéré; M P Audrézet; B Mercier; C Férec
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

8.  Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR.

Authors:  P J Thomas; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

9.  Two new mutations detected by single-strand conformation polymorphism analysis in cystic fibrosis from Russia.

Authors:  T E Ivaschenko; V S Baranov; M Dean
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

Review 10.  Spectrum of mutations in cystic fibrosis.

Authors:  G R Cutting
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.